Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Ocugen Inc
OCGN
Healthcare
Biotechnology
Ocugen, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. Its technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. The Company is developing...
its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal disease (IRDs), including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardt disease and multifactorial diseases such as dry age-related macular degeneration (dAMD) and geographic atrophy (GA). It is developing an inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:OCGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
Next
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Dec 31, 2021 10:02pm
FSD Pharma Announces Share Repurchase Program
FSD Pharma Announces Share Repurchase Program TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding
...more
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Dec 19, 2021 8:03pm
OCGN - These 5 Stocks Will Be Under The Spotlight Monday
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Dec 10, 2021 1:38am
FSD Pharma Establishes New Regulatory Advisory Board
FSD Pharma Establishes New Regulatory Advisory Board with the Appointment of Joga Gobburu, Ph.D., and Mary Melnyk, Ph.D., as Members Regulatory Advisory Board will oversee the drug development
...more
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Dec 06, 2021 9:23pm
H.C. Wainwright 2nd Annual Psychedelics Virtual Conference
FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD
...more
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Dec 03, 2021 10:09pm
FSD Pharma at the H.C. Wainwright 2nd Annual Psychedelics
FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD
...more
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Dec 03, 2021 1:58am
FSD Pharma: Demonstrating the Positive Effects of Lucid-MS
FSD Pharma Unveils Videos Demonstrating Positive Effects of
...more
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Dec 01, 2021 7:36pm
📰📣iMining Technologies Launches Concierge Service📢📣📣
↓↓↓↓↓↓↓↓↓↓↓↓↓Click the link for the Full Details of the Article: ↓↓↓↓↓↓↓↓↓↓↓↓↓ BitBit Financial Inc., a wholly owned subsidiary of iMining Technologies Inc., has set-up concierge
...more
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Nov 26, 2021 10:04pm
🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣
(3)
•••
Richardson35
X
View Profile
View Bullboard History
Post by
Richardson35
on Nov 23, 2021 7:22pm
📰📣Anthony Durkacz on Building a Turnaround at FSD Pharma🎥
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Nov 06, 2021 4:29pm
OCGN - Friday Rundown, Monday Expectations
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Nov 02, 2021 4:32pm
OCGN - What's Next
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Nov 01, 2021 2:05pm
OCGN - Showing Signs of a Great Run
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Oct 31, 2021 5:24pm
OCGN - Friday Rundown, Monday Expectations
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Oct 29, 2021 1:03pm
OCGN - Update
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Oct 28, 2021 2:27am
OCGN - Wednesday Rundown, Thursday Expectations
Prev
1
2
3
4
5
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth